# Changes in Bone Turnover With Increased Incretin Hormone Exposure

> **NCT01374568** · PHASE4 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 6 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** sitagliptin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01374568
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2012-07-06
- **Final completion:** 2015-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study closed by sponsor. Funding ended.
- **Last updated:** 2017-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01374568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01374568, "Changes in Bone Turnover With Increased Incretin Hormone Exposure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01374568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*